68 reports

  • Risk Factors for Pancreatic Cancer
  • 2 Pancreatic Cancer: Executive Summary

Table ##: Risk Factors for Pancreatic Cancer Risk Factors Description Source Smoking The risk of pancreatic cancer increases with age.

  • Pancreatic Cancer
  • Japan
  • United States
  • World
  • Forecast

Global Pancreatic Cancer Therapeutics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025 ##.

  • Cancer
  • Pancreatic Cancer
  • World
  • Market Size

Market Spotlight: Pancreatic Cancer ## OVERVIEW ## KEY TAKEAWAYS ## DISEASE BACKGROUND ## Subtypes ## TREATMENT ## Surgery ## Ablation or embolization ## Radiation therapy ## Chemotherapy ## Targeted therapy ## Immunotherapy ## Drugs used specifically for the treatment of PN

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United States
  • Masiviera's Development in Pancreatic Cancer
  • Abraxane's Development in Pancreatic Cancer

INITIALLY APPROVED IN JAPAN FOR GASTRIC CANCER IN 1999, TS-## WAS SUBSEQUENTLY APPROVED FOR PANCREATIC CANCER IN 2006.

  • Pancreatic Cancer
  • AbbVie Inc.
  • AstraZeneca PLC
  • Halozyme Therapeutics, Inc.
  • Merck & Co., Inc.

Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Pancreatic Cancer
  • France
  • United States
  • World
  • Forecast

Europe Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Pancreatic Cancer
  • Europe
  • France
  • Germany
  • Forecast

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Pancreatic Cancer
  • France
  • Germany
  • United States
  • Market Size

Pancreatic cancer

4385 5000 3900
  • Epidemiology: Pancreatic Cancer
  • LEADING TREATMENTS FOR PANCREATIC CANCER

BIBLIOGRAPHY Pancreatic cancer Disease Coverage | Forecast: Pancreatic Cancer DMKC## US ## ## ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ##

  • Pancreatic Cancer
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • NewLink Genetics Corporation
  • Taiho Pharmaceutical Co., Ltd.

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Pancreatic Cancer
  • France
  • Germany
  • Italy
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Japan
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United States
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United Kingdom
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Italy
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Germany
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • France
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Spain
  • Market Size

Pancreatic Cancer Global Clinical Trials Review, H##, 2020 List of Tables List of Figures Report Guidance GlobalData Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Trials in Asia

  • Cancer
  • Clinical Trial
  • Drug Development
  • Pancreatic Cancer
  • World

Pancreatic cancer Global Clinical Trials Review, H##, 2019 List of Tables ## List of Figures ## Report Guidance ## GlobalData Clinical Trials Report Coverage ## Clinical Trials by Region ## Clinical Trials and Average Enrollment by Country ## Top Five Countries Contributing to Clinical Tr

  • Cancer
  • Clinical Trial
  • Drug Development
  • Pancreatic Cancer
  • World
  • PANCREATIC CANCER SURVIVAL RATE
  • PROGNOS PANCREATIC CANCER DIAGNOSIS TEST RESULT VARIANCE

Prognos has been performing an extensive investigation into pancreatic cancer.

  • Artificial Intelligence
  • Hospital
  • Pancreatic Cancer
  • United States
  • GE Healthcare Limited

Drug Analysis: Masitinib Product Profiles masitinib : Prostate cancer masitinib : Colorectal cancer (CRC) masitinib : Asthma masitinib : Pancreatic cancer LIST OF FIGURES Figure ##: Masitinib for prostate cancer – SWOT analysis Figure ##: Datamoni

  • Colorectal Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • European Union
  • United States

Drug Overview: Masitinib TABLE OF CONTENTS ## Product Profiles## masitinib : Prostate cancer ## masitinib : Colorectal cancer (CRC) ## masitinib : Asthma ## masitinib : Pancreatic cancer LIST OF FIGURES ## Figure ##: Masitinib for prostate cancer

  • Colorectal Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • European Union
  • United States
  • STAGES AND LOCATION OF PANCREATIC CANCER
  • Staging of Pancreatic Cancer

Table ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology

Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas.

  • Pancreatic Cancer
  • Therapy

Similarly, the Universities portfolio in Phase II, Phase I, Phase ##, IND/ CTA Filed, Preclinical and Discovery stages comprises ##, ##, ##, ##, ## and ## molecules, respectively.

  • Pancreatic Cancer
  • Therapy

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U. S.

  • Cancer
  • Pancreatic Cancer
  • United States
  • Forecast
  • Market Size

Metastatic Pancreatic Cancer Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Metastatic Pancreatic Cancer Trials ## Clinical Trials Trends to ##

  • Cancer
  • Clinical Trial
  • Drug Development
  • Pancreatic Cancer
  • Pathology
  • Nov 02, 2018: Bavarian Nordic announces initiation of clinical trial evaluating the combination therapy of CV301 and Durvalumab in metastatic colorectal and pancreatic cancers
  • Pipeline by Etubics Corp, H1 2019

One of these trials was completed at Rutgers Cancer Institute in patients with pancreatic cancer.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Pancreatic Cancer
  • Therapy
  • Etubics Corporation
  • NANOKNIFE SYSTEM - STAGE III PANCREATIC CANCER - IRE: ANTI-TUMOR IMMUNITY INDUCED BY IRE OF UNRESECTABLE PANCREATIC CANCER
  • NANOKNIFE SYSTEM - STAGE III PANCREATIC CANCER CLINICAL TRIAL DETAILS

Regardless of the stage of pancreatic cancer, it is one of the least survivable cancers, and survival rates have not improved substantially for more than forty years.

  • Clinical Trial
  • Pancreatic Cancer
  • Prostate Cancer
  • United States
  • AngioDynamics, Inc.
  • Small Molecules to Inhibit Pim Kinase for Pancreatic Cancer - Drug Profile
  • Apr 04, 2014: Roswell Park to Present Findings on Jasco Pharmaceuticals' Novel PIM Inhibitor at AACR 2014

The drug candidate is in preclinical stage of development for solid tumors including breast cancer, colon cancer, liver cancer, lung cancer, pancreatic cancer, acute myelocytic leukemia, relapsed and refractory multiple myeloma.

  • Pancreatic Cancer
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Funding for Research in Pancreatic Cancer
  • Awareness Projects for Pancreatic Cancer

Pancreatic cancer is often referred to as one of the most deadly form of cancer and is known to be a " silent cancer".

  • Pancreatic Cancer
  • World
  • Forecast
  • Market Size
  • PharmaCyte Biotech, Inc.